<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="sub-topic" /><meta name="keywords" content="Analgesics: NSAIDs: poisoning by; Paracetamol: poisoning by; Acetylcysteine: paracetamol poisoning; Methionine" /><meta name="IX" content="Analgesics: NSAIDs: poisoning by; Paracetamol: poisoning by; Acetylcysteine: paracetamol poisoning; Methionine" /><title>Analgesics (non-opioid): British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="59/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="PHP0-publication-information.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="PHP188-analgesics-non-opioid.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="PHP188-analgesics-non-opioid.htm#pB" title="Skip Navigation">Skip Navigation</a><img src="../../images/mylogo.png" alt="BNF.org Free Access" id="pI" /><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=PHP188-analgesics-non-opioid.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 06 Oct 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF September 2012</a> &gt; <a href="PHP170-emergency-treatment-of-poisoning.htm">Emergency treatment of poisoning</a> &gt; <a href="PHP186-specific-drugs.htm">Specific drugs</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="PHP187-alcohol.htm" title="Previous: Alcohol">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="PHP195-acetylcysteine.htm" title="Next: ACETYLCYSTEINE">Next page</a> ►</div></div></div></div><div id="p1"><div id="sideBar"><h2>See Also</h2><ul><li><h3>AHFS Drug Information (2)</h3></li><li><a href="http://www.medicinescomplete.com/mc/ahfs/2010/a381004.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Acetaminophen</a><div class="breadcrumb"><p><strong>AHFS Drug Information</strong> &gt; Central Nervous System Agents 28:00 &gt; Analgesics and Antipyretics 28:08 &gt; Analgesics and Antipyretics, Miscellaneous 28:08.92</p></div></li><li><a href="http://www.medicinescomplete.com/mc/ahfs/2010/a382638.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Acetylcysteine</a><div class="breadcrumb"><p><strong>AHFS Drug Information</strong> &gt; Miscellaneous Therapeutic Agents 92:00 &gt; Antidotes 92:12</p></div></li></ul><ul><li><h3>Stockley's Interaction Alerts (3)</h3></li><li><a href="http://www.medicinescomplete.com/mc/alerts/2010/3701-r.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Acetylcysteine</a><div class="breadcrumb"><p><strong>Stockley's Interaction Alerts</strong> &gt; Interactants: A &gt; Interactions of Acetylcysteine</p></div></li><li><a href="http://www.medicinescomplete.com/mc/alerts/2010/605-x.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Methionine</a><div class="breadcrumb"><p><strong>Stockley's Interaction Alerts</strong> &gt; Interactants: M &gt; Interactions of Methionine</p></div></li><li><a href="http://www.medicinescomplete.com/mc/alerts/2010/2679-p.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Paracetamol</a><div class="breadcrumb"><p><strong>Stockley's Interaction Alerts</strong> &gt; Interactants: P &gt; Interactions of Paracetamol</p></div></li></ul><ul><li><h3>British National Formulary (66)</h3></li><li><a href="PHP79-controlled-drugs-and-drug-dependence.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Controlled Drugs and drug dependence</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; Guidance on prescribing</p></div></li><li><a href="PHP114-pain.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Pain</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; Guidance on prescribing &gt; Prescribing in palliative care</p></div></li><li><a href="PHP141-adverse-reactions.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Adverse reactions</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; Guidance on prescribing &gt; Prescribing for the elderly</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22analgesics%22%22paracetamol%22%22acetylcysteine%22%22methionine%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (66)</a></li></ul><ul><li><h3>BNF for Children (42)</h3></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/PHP10953-prescribing-controlled-drugs.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Prescribing Controlled Drugs</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; General guidance</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/PHP10973-pain.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Pain</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; General guidance &gt; Prescribing in palliative care</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/PHP11018-analgesics-non-opioid.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Analgesics (non-opioid)</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; Emergency treatment of poisoning &gt; Specific drugs</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22analgesics%22%22paracetamol%22%22acetylcysteine%22%22methionine%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (42)</a></li></ul><ul><li><h3>Clarke's Analysis of Drugs and Poisons (59)</h3></li><li><a href="http://www.medicinescomplete.com/mc/clarke/2010/c-d1e13264.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Acetylcysteine</a><div class="breadcrumb"><p><strong>Clarke's Analysis of Drugs and Poisons</strong> &gt; Monographs &gt; Alphabetically &gt; A</p></div></li><li><a href="http://www.medicinescomplete.com/mc/clarke/2010/c-d1e25489.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Aflatoxins M</a><div class="breadcrumb"><p><strong>Clarke's Analysis of Drugs and Poisons</strong> &gt; Monographs &gt; Alphabetically &gt; A</p></div></li><li><a href="http://www.medicinescomplete.com/mc/clarke/2010/CLK1738.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Amicarbalide</a><div class="breadcrumb"><p><strong>Clarke's Analysis of Drugs and Poisons</strong> &gt; Monographs &gt; Alphabetically &gt; A</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22analgesics%22%22paracetamol%22%22acetylcysteine%22%22methionine%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (59)</a></li></ul><ul><li><h3>Dietary Supplements (2)</h3></li><li><a href="http://www.medicinescomplete.com/mc/diet/2010/c81.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Pycnogenol</a><div class="breadcrumb"><p><strong>Dietary Supplements</strong> &gt; Monographs &gt; P</p></div></li><li><a href="http://www.medicinescomplete.com/mc/diet/2010/c87.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">S-Adenosyl methionine</a><div class="breadcrumb"><p><strong>Dietary Supplements</strong> &gt; Monographs &gt; S</p></div></li></ul><ul><li><h3>Pharmaceutical Excipients (28)</h3></li><li><a href="http://www.medicinescomplete.com/mc/excipients/2012/1001937106.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Crospovidone</a><div class="breadcrumb"><p><strong>Pharmaceutical Excipients</strong> &gt; Monographs &gt; Alphabetically &gt; C</p></div></li><li><a href="http://www.medicinescomplete.com/mc/excipients/2012/1001937521.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Dibutyl Phthalate</a><div class="breadcrumb"><p><strong>Pharmaceutical Excipients</strong> &gt; Monographs &gt; Alphabetically &gt; D</p></div></li><li><a href="http://www.medicinescomplete.com/mc/excipients/2012/1001937824.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Dimethyl Phthalate</a><div class="breadcrumb"><p><strong>Pharmaceutical Excipients</strong> &gt; Monographs &gt; Alphabetically &gt; D</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22analgesics%22%22paracetamol%22%22acetylcysteine%22%22methionine%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (28)</a></li></ul><ul><li><h3>Herbal Medicines</h3></li><li><a href="http://www.medicinescomplete.com/mc/herbals/2011/HBL218254.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Melilot</a><div class="breadcrumb"><p><strong>Herbal Medicines</strong> &gt; Monographs &gt; M</p></div></li></ul><ul><li><h3>Handbook on Injectable Drugs</h3></li><li><a href="http://www.medicinescomplete.com/mc/hid/2010/a506001.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Acetylcysteine</a><div class="breadcrumb"><p><strong>Handbook on Injectable Drugs</strong> &gt; Monographs &gt; A</p></div></li></ul><ul><li><h3>Stability-Indicating HPLC Methods for Drug Analysis (2)</h3></li><li><a href="http://www.medicinescomplete.com/mc/hplc/2008/ch0001s0012.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Acetaminophen</a><div class="breadcrumb"><p><strong>Stability-Indicating HPLC Methods for Drug Analysis</strong> &gt; Monographs &gt; A</p></div></li><li><a href="http://www.medicinescomplete.com/mc/hplc/2008/ch0001s0051.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Acetylcysteine</a><div class="breadcrumb"><p><strong>Stability-Indicating HPLC Methods for Drug Analysis</strong> &gt; Monographs &gt; A</p></div></li></ul><ul><li><h3>Injectable Drugs Guide (2)</h3></li><li><a href="http://www.medicinescomplete.com/mc/idg/2010/A04-mn0001.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Acetylcysteine</a><div class="breadcrumb"><p><strong>Injectable Drugs Guide</strong> &gt; Injectable Drugs Guide &gt; Monographs &gt; A</p></div></li><li><a href="http://www.medicinescomplete.com/mc/idg/2010/p09-mn0001.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Paracetamol (acetaminophen)</a><div class="breadcrumb"><p><strong>Injectable Drugs Guide</strong> &gt; Injectable Drugs Guide &gt; Monographs &gt; P</p></div></li></ul><ul><li><h3>Martindale: The Complete Drug Reference (66)</h3></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/12355-b.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Amicarbalide Isetionate</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Archive of Deleted Monographs &gt; Drug Monographs</p></div></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/753-s.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Amphotalide</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Archive of Deleted Monographs &gt; Drug Monographs</p></div></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/12410-a.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Azalomycin</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Archive of Deleted Monographs &gt; Drug Monographs</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22analgesics%22%22paracetamol%22%22acetylcysteine%22%22methionine%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (66)</a></li></ul><ul><li><h3>The Merck Index (19)</h3></li><li><a href="http://www.medicinescomplete.com/mc/merck/2010/00047.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Acetaminophen</a><div class="breadcrumb"><p><strong>The Merck Index</strong> &gt; Monographs &gt; A &gt; AC</p></div></li><li><a href="http://www.medicinescomplete.com/mc/merck/2010/00088.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Acetylcysteine</a><div class="breadcrumb"><p><strong>The Merck Index</strong> &gt; Monographs &gt; A &gt; AC</p></div></li><li><a href="http://www.medicinescomplete.com/mc/merck/2010/00182.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Aflatoxins M</a><div class="breadcrumb"><p><strong>The Merck Index</strong> &gt; Monographs &gt; A &gt; AF</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22analgesics%22%22paracetamol%22%22acetylcysteine%22%22methionine%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (19)</a></li></ul><ul><li><h3>Remington: The Science and Practice of Pharmacy (7)</h3></li><li><a href="http://www.medicinescomplete.com/mc/rem/2012/c12-sec1-009.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Nomenclature for Various Special Products</a><div class="breadcrumb"><p><strong>Remington: The Science and Practice of Pharmacy</strong> &gt; Part 1: The Science of Pharmacy &gt; Section 2: Pharmaceutical Chemistry &gt; 12 Drug Nomenclature—United States Adopted Names</p></div></li><li><a href="http://www.medicinescomplete.com/mc/rem/2012/c23-sec1-007.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Drug Development</a><div class="breadcrumb"><p><strong>Remington: The Science and Practice of Pharmacy</strong> &gt; Part 1: The Science of Pharmacy &gt; Section 4: Pharmaceutics &gt; 23 Modern-Day Drug Discovery and Development</p></div></li><li><a href="http://www.medicinescomplete.com/mc/rem/2012/c79-sec1-008.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">US Public Health Service (www.usphs.gov)</a><div class="breadcrumb"><p><strong>Remington: The Science and Practice of Pharmacy</strong> &gt; Part 2: The Practice of Pharmacy &gt; Section 8: The Scope of Pharmacy Practice &gt; 79 Pharmacists in Government</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22analgesics%22%22paracetamol%22%22acetylcysteine%22%22methionine%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (7)</a></li></ul><ul><li><h3>Stockley's Herbal Medicines Interactions</h3></li><li><a href="http://www.medicinescomplete.com/mc/shmi/2011/210463.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Clove</a><div class="breadcrumb"><p><strong>Stockley's Herbal Medicines Interactions</strong> &gt; Clove</p></div></li></ul><ul><li><h3>Stockley's Drug Interactions (5)</h3></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/int-E0E0E6E3E0R0D626.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Acetylcysteine</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically &gt; A</p></div></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/int-E2E0E8E3E0R0D2024.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Analgesics</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically &gt; A</p></div></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/intalpha-M.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactants: M</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22analgesics%22%22paracetamol%22%22acetylcysteine%22%22methionine%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (5)</a></li></ul><ul><li><h3>Drug Administration via Enteral Feeding Tubes (2)</h3></li><li><a href="http://www.medicinescomplete.com/mc/tubes/2010/c17.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Acetylcysteine</a><div class="breadcrumb"><p><strong>Drug Administration via Enteral Feeding Tubes</strong> &gt; Handbook of Drug Administration via Enteral Feeding Tubes &gt; Monographs &gt; A</p></div></li><li><a href="http://www.medicinescomplete.com/mc/tubes/2010/c296.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Paracetamol</a><div class="breadcrumb"><p><strong>Drug Administration via Enteral Feeding Tubes</strong> &gt; Handbook of Drug Administration via Enteral Feeding Tubes &gt; Monographs &gt; P</p></div></li></ul><script type="text/javascript" src="scripts/sidebar.js"></script></div><div id="pB"><h1>Analgesics (non-opioid)</h1><?highlighter on?><div id="pC" class="jN"><div id="PHP189"><h2>Aspirin</h2><p>The main features of salicylate poisoning are hyperventilation, tinnitus, deafness, vasodilatation, and sweating. Coma is uncommon but indicates very severe poisoning. The associated acid-base disturbances are complex.</p><p>Treatment must be in hospital, where plasma salicylate, pH, and electrolytes can be measured; absorption of aspirin may be slow and the plasma-salicylate concentration may continue to rise for several hours, requiring repeated measurement. Plasma-salicylate concentration may not correlate with clinical severity in the young and the elderly, and clinical and biochemical assessment is necessary. Generally, the clinical severity of poisoning is less below a plasma-salicylate concentration of 500 mg/litre (3.6 mmol/litre), unless there is evidence of metabolic acidosis. Activated charcoal can be given within 1 hour of ingesting more than 125 mg/kg of aspirin. Fluid losses should be replaced and intravenous sodium bicarbonate may be given (ensuring plasma-potassium concentration is within the reference range) to enhance urinary salicylate excretion (optimum urinary pH 7.5–8.5).</p><p>Plasma-potassium concentration should be corrected before giving sodium bicarbonate as hypokalaemia may complicate alkalinisation of the urine.</p><p>Haemodialysis is the treatment of choice for severe salicylate poisoning and should be considered when the plasma-salicylate concentration exceeds 700 mg/litre (5.1 mmol/litre) or in the presence of severe metabolic acidosis.</p></div><div id="PHP190"><h2>NSAIDs</h2><p>Mefenamic acid has important consequences in overdosage because it can cause convulsions, which if prolonged or recurrent require treatment, see <a title="topic: Convulsions" href="PHP177-convulsions.htm">Convulsions</a>.</p><p>Overdosage with ibuprofen may cause nausea, vomiting, epigastric pain, and tinnitus, but more serious toxicity is very uncommon. Activated charcoal followed by symptomatic measures are indicated if more than 100 mg/kg has been ingested within the preceding hour.</p></div><div id="PHP191"><h2>Paracetamol</h2><div class="cI"><p>In cases of <strong>intravenous paracetamol</strong> poisoning contact the National Poisons Information Service for advice on risk assessment and management.</p></div><p>Single or repeated doses totalling as little as 10–15 g (20–30 tablets) or 150 mg/kg of paracetamol ingested within 24 hours may cause severe hepatocellular necrosis and, much less frequently, renal tubular necrosis. However, liver toxicity may develop at doses as low as 75 mg/kg of paracetamol (equivalent to approx. 5 g (10 tablets) in a 70-kg patient) taken within 24 hours by patients at high-risk of liver-damage, including those taking liver enzyme-inducing drugs (e.g. carbamazepine, phenobarbital, phenytoin, primidone, rifampicin, rifabutin, efavirenz, nevirapine, alcohol, and St John's wort), or those who are malnourished (e.g. in anorexia or bulimia, cystic fibrosis, hepatits C, in alcoholism, or those who are HIV-positive), or those who have not eaten for a few days. To avoid underestimating the potentially toxic paracetamol dose ingested by obese patients who weigh more than 110 kg, use a body-weight of 110 kg (rather than their actual body-weight) when calculating the total dose of paracetamol ingested (in mg/kg). </p><p>Nausea and vomiting, the only early features of poisoning, usually settle within 24 hours. Persistence beyond this time, often associated with the onset of right subcostal pain and tenderness, usually indicates development of hepatic necrosis. Liver damage is maximal 3–4 days after paracetamol overdose and may lead to encephalopathy, haemorrhage, hypoglycaemia, cerebral oedema, and death. Therefore, despite a lack of significant early symptoms, patients who have taken an overdose of paracetamol should be transferred to hospital urgently.</p><p>Administration of activated charcoal should be considered if paracetamol in excess of 150 mg/kg or 12 g, <strong>whichever is the smaller</strong> (or in excess of 75 mg/kg for those considered to be at high risk, see above), is thought to have been ingested within the previous hour.</p><p><strong>Acetylcysteine</strong> protects the liver if infused up to, and possibly beyond, 24 hours of ingesting paracetamol. It is most effective if given within 8 hours of ingestion, after which effectiveness declines. Acetylcysteine treatment should commence immediately in patients:</p><ul><li><p>who have ingested a potentially toxic amount of paracetamol (irrespective of the plasma-paracetamol concentration) when there is uncertainty about the time of overdose; </p></li><li><p>who have taken a ‘staggered overdose’ (irrespective of the plasma-paracetamol concentration) where the paracetamol has been ingested over more than one hour;</p></li><li><p>whose plasma-paracetamol concentration falls on or above the treament line on the paracetamol treatment graph (see <a title="target-block: paracetamol graph" href="PHP188-analgesics-non-opioid.htm#PHP193">Paracetamol poisoning treatment graph</a>);<em> </em></p></li><li><p>who present 8–36 hours after a potentially toxic ingestion of paracetamol, even if plasma-paracetamol concentrations are not yet available; if more than 24 hours have elapsed since ingestion advice should be sought from the National Poisons Information Service.</p></li></ul><p>Very rarely, giving acetylcysteine by mouth [unlicensed route] is an alternative if intravenous access is not possible—contact the National Poisons Information Service for advice. In remote areas, <strong>methionine</strong> by mouth is an alternative only if acetylcysteine cannot be given promptly. Once the patient reaches hospital the need to continue treatment with the antidote will be assessed on the basis of the circumstances surrounding the overdose, and, if necessary, the plasma-paracetamol concentration (related to the time from ingestion).</p><p>Patients at risk of liver damage and, therefore, requiring treatment, can be identified from a single measurement of the plasma-paracetamol concentration, related to the time from ingestion, provided this time interval is not less than 4 hours; earlier samples may be misleading. The concentration is plotted on a paracetamol treatment graph, with a reference line (‘treatment line’) joining plots of 100 mg/litre (0.66 mmol/litre) at 4 hours and 3.13 mg/litre (0.02 mmol/litre) at 24 hours (see <a title="target-block: paracetamol graph" href="PHP188-analgesics-non-opioid.htm#PHP193">Paracetamol poisoning treatment graph</a>). Those whose plasma-paracetamol concentration is on or above the <em> treatment line</em> are treated with acetylcysteine by intravenous infusion (or, if acetylcysteine is not available, with methionine by mouth, provided the overdose has been taken <strong>within 10–12 hours</strong> <em>and</em> the patient is not vomiting). The single treatment line is applicable whether or not patients have additional risk factors for liver toxicity.</p>  <p>The prognostic accuracy of a plasma-paracetamol concentration taken after 15 hours is uncertain, but a concentration on or above the treatment line should be regarded as carrying a serious risk of liver damage.</p><p>The plasma-paracetamol concentration is difficult to interpret when a 'staggered overdose' has been ingested. If there is doubt about timing or the need for treatment then the patient should be treated with an antidote.</p><div><div class="cE"><h3 class="cT">Acetylcysteine dose and administration</h3> <p class="cT">For paracetamol overdosage, acetylcysteine is given in a total dose that is divided into 3 consecutive intravenous infusions over a total of 21 hours. The tables below include the dose of acetylcysteine, for adults and children of body-weight 40 kg and over, in terms of the volume of Acetylcysteine Concentrate for Intravenous Infusion required for each of the 3 infusions. The requisite dose of acetylcysteine is added to Glucose Intravenous Infusion 5%.</p></div></div><div class="cG"><div class="cE"><h3 class="cT">Note</h3> <p class="cT">Glucose Intravenous Infusion 5% is the preferred fluid; Sodium Chloride Intravenous Infusion 0.9% is an alternative if Glucose Intravenous Infusion 5 % is unsuitable</p></div></div><p><em>First infusion</em> (based on an acetylcysteine dose of approx. 150 mg/kg)—add requisite volume of Acetylcysteine Concentrate for Intravenous Infusion to 200 mL Glucose Intravenous Infusion 5%; infuse over 1 hour.</p><div class="table"><table class="table" cellspacing="0" cellpadding="8" border="0" style="border-collapse: collapse;border-top: 1pt solid ; border-bottom: 1pt solid ; border-left: 1pt solid ; border-right: 1pt solid ; "><colgroup><col style="text-align: center;" /><col style="text-align: center;" /></colgroup><thead><tr style="border-bottom: 1pt solid ; "><th style="border-right: 1pt solid ; border-bottom: 1pt solid ; text-align: center;">Body-weight</th><th style="border-right: 1pt solid ; border-bottom: 1pt solid ; text-align: center;">Volume of Acetylcysteine Concentrate for Intravenous Infusion 200 mg/mL required to prepare first infusion</th></tr></thead><tbody><tr><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; text-align: center;">40–49 kg</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; text-align: center;">34 mL</td></tr><tr><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; text-align: center;">50–59 kg</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; text-align: center;">42 mL</td></tr><tr><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; text-align: center;">60–69 kg</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; text-align: center;">49 mL</td></tr><tr><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; text-align: center;">70–79 kg</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; text-align: center;">57 mL</td></tr><tr><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; text-align: center;">80–89 kg</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; text-align: center;">64 mL</td></tr><tr><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; text-align: center;">90–99 kg</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; text-align: center;">72 mL</td></tr><tr><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; text-align: center;">100–109 kg</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; text-align: center;">79 mL</td></tr><tr><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; text-align: center;">≥110 kg</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; text-align: center;">83 mL (max. dose)</td></tr></tbody></table></div><p><em>Second infusion</em> (based on an acetylcysteine dose of approx. 50 mg/kg; start immediately after completion of first infusion)—add requisite volume of Acetylcysteine Concentrate for Intravenous Infusion to 500 mL Glucose Intravenous Infusion 5%; infuse over 4 hours.</p><div class="table"><table class="table" cellspacing="0" cellpadding="8" border="0" style="border-collapse: collapse;border-top: 1pt solid ; border-bottom: 1pt solid ; border-left: 1pt solid ; border-right: 1pt solid ; "><colgroup><col style="text-align: center;" /><col style="text-align: center;" /></colgroup><thead><tr style="border-bottom: 1pt solid ; "><th style="border-right: 1pt solid ; border-bottom: 1pt solid ; text-align: center;">Body-weight</th><th style="border-right: 1pt solid ; border-bottom: 1pt solid ; text-align: center;">Volume of Acetylcysteine Concentrate for Intravenous Infusion 200 mg/mL required to prepare second infusion</th></tr></thead><tbody><tr><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; text-align: center;">40–49 kg</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; text-align: center;">12 mL</td></tr><tr><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; text-align: center;">50–59 kg</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; text-align: center;">14 mL</td></tr><tr><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; text-align: center;">60–69 kg</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; text-align: center;">17 mL</td></tr><tr><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; text-align: center;">70–79 kg</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; text-align: center;">19 mL</td></tr><tr><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; text-align: center;">80–89 kg</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; text-align: center;">22 mL</td></tr><tr><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; text-align: center;">90–99 kg</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; text-align: center;">24 mL</td></tr><tr><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; text-align: center;">100–109 kg</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; text-align: center;">27 mL</td></tr><tr><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; text-align: center;">≥110 kg</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; text-align: center;">28 mL (max. dose)</td></tr></tbody></table></div><p><em>Third infusion</em> (based on an acetylcysteine dose of approx. 100 mg/kg; start immediately after completion of second infusion)—add requisite volume of Acetylcysteine Concentrate for Intravenous Infusion to 1 litre Glucose Intravenous Infusion 5%; infuse over 16 hours</p><div class="table"><table class="table" cellspacing="0" cellpadding="8" border="0" style="border-collapse: collapse;border-top: 1pt solid ; border-bottom: 1pt solid ; border-left: 1pt solid ; border-right: 1pt solid ; "><colgroup><col style="text-align: center;" /><col style="text-align: center;" /></colgroup><thead><tr style="border-bottom: 1pt solid ; "><th style="border-right: 1pt solid ; border-bottom: 1pt solid ; text-align: center;">Body-weight</th><th style="border-right: 1pt solid ; border-bottom: 1pt solid ; text-align: center;">Volume of Acetylcysteine Concentrate for Intravenous Infusion 200 mg/mL required to prepare third infusion</th></tr></thead><tbody><tr><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; text-align: center;">40–49 kg</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; text-align: center;">23 mL</td></tr><tr><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; text-align: center;">50–59 kg</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; text-align: center;">28 mL</td></tr><tr><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; text-align: center;">60–69 kg</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; text-align: center;">33 mL</td></tr><tr><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; text-align: center;">70–79 kg</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; text-align: center;">38 mL</td></tr><tr><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; text-align: center;">80–89 kg</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; text-align: center;">43 mL</td></tr><tr><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; text-align: center;">90–99 kg</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; text-align: center;">48 mL</td></tr><tr><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; text-align: center;">100–109 kg</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; text-align: center;">53 mL</td></tr><tr><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; text-align: center;">≥110 kg</td><td style="border-right: 1pt solid ; border-bottom: 1pt solid ; text-align: center;">55 mL (max. dose)</td></tr></tbody></table></div><p id="PHP193"><img src="images/paracetamol_graph.png" alt="Paracetamol poisoning treatment graph" /></p></div></div><div id="pS"><p>Sub-sections</p><ul class="jT"><li id="_PHP195-acetylcysteine"><a href="PHP195-acetylcysteine.htm" title="ACETYLCYSTEINE">ACETYLCYSTEINE</a></li><li id="_PHP198-methionine"><a href="PHP198-methionine.htm" title="METHIONINE">METHIONINE</a></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="PHP187-alcohol.htm">Previous: Alcohol</a> | <a class="top" href="PHP188-analgesics-non-opioid.htm#">Top</a> | <a accesskey="]" href="PHP195-acetylcysteine.htm">Next: ACETYLCYSTEINE</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Cookie and Privacy Policy">Cookie and Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="PHP0-publication-information.htm" rel="copyright">Copyright © BMJ Group and Pharmaceutical Press 2012. All rights reserved. </a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>